FDA issued a Warning Letter to Haw Par Healthcare Limited on 8/19/2019 for a later inspection.
483 Haw Par Healthcare Oct 2009

483 Haw Par Healthcare Oct 2009

Jose Hernandez FDA, Javier Vega FDA$119.00 - Available Now

FDA investigators audited the Haw Par Healthcare - Singapore, Singapore facility and issued inspectional observations (via FDA 483) on 29 Oct 2009.

Product details

  • Category: Human Drugs
  • Inspection end: 29 Oct 2009
  • Location: Singapore, Singapore
  • FEI: 3001432470
Add To Cart